{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:28:16Z","timestamp":1777292896185,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12325-019-00931-8","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T16:35:47Z","timestamp":1554741347000},"page":"1497-1508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Observational Prospective Study to Determine the Evolution of the Symptomatic Profile of Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients and Its Relation to the Control of the Disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Manuel","family":"D\u00f3mine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartomeu","family":"Massuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Calles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Triguboff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashmin Silvana","family":"Afonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Giron\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Aparisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Oramas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"931_CR1","unstructured":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM). Las Cifras del C\u00e1ncer en Espa\u00f1a 2019. SEOM.\u00a0 https:\/\/seom.org\/dmcancer\/wp-content\/uploads\/2019\/informe-SEOM-cifras-cancer-2019.pdf ."},{"key":"931_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","volume":"361","author":"TS Mok","year":"2009","unstructured":"Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361:947\u201357.","journal-title":"N Engl J Med"},{"key":"931_CR3","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","volume":"368","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib vs. chemotherapy in advanced ALK-positive lung cancer. N Engl J Med. 2013;368:2385\u201394.","journal-title":"N Engl J Med"},{"key":"931_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","volume":"371","author":"BJ Solomon","year":"2014","unstructured":"Solomon BJ, Mok T, Kim DW, et al. First line crizotinib vs. chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014;371:2167\u201377.","journal-title":"N Engl J Med"},{"key":"931_CR5","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","volume":"371","author":"AT Shaw","year":"2014","unstructured":"Shaw AT, Ou SH, Bang YJ, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2014;371:1963\u201371.","journal-title":"N Engl J Med"},{"issue":"2","key":"931_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.lungcan.2013.03.004","volume":"81","author":"YL Wu","year":"2013","unstructured":"Wu YL, Fukuoka M, Mok TS, et al. Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: post hoc analyses from the IPASS study. Lung Cancer. 2013;81(2):280\u20137.","journal-title":"Lung Cancer"},{"issue":"9","key":"931_CR7","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s11136-006-0009-9","volume":"15","author":"EP Brabo","year":"2006","unstructured":"Brabo EP, Paschoal ME, Biasoli I, Nogueira FE, Gomes MC, Gomes IP. Brazilian version of the QLQ-LC13 lung cancer module of the European Organization for Research and Treatment of Cancer: preliminary reliability and validity report. Qual Life Res. 2006;15(9):1519\u201324.","journal-title":"Qual Life Res"},{"key":"931_CR8","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"A Sandler","year":"2006","unstructured":"Sandler A, Grey R, Perry MC, et al. Paclitaxel\u2013Carboplatin alone or with bevacizumab for non\u2013small-cell lung cancer. N Engl J Med. 2006;355:2542\u201350.","journal-title":"N Engl J Med"},{"key":"931_CR9","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1200\/JCO.2007.14.5466","volume":"27","author":"M Reck","year":"2009","unstructured":"Reck M, von Pawell J, Zatloukal P, et al. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol. 2009;27:1227\u201334.","journal-title":"J Clin Oncol"},{"key":"931_CR10","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","volume":"26","author":"GV Scagliotti","year":"2008","unstructured":"Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 2008;26:3543\u201351.","journal-title":"J Clin Oncol"},{"key":"931_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1056\/NEJMoa011954","volume":"346","author":"JH Schiller","year":"2002","unstructured":"Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non\u2013small-cell lung cancer. N Engl J Med. 2002;346:92\u20138.","journal-title":"N Engl J Med"},{"key":"931_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, et al. Pembrolizumab versus chemotherapy for PD-L1-Positive non-small-cell lung cancer. N Engl J Med. 2016;375:1823\u201333.","journal-title":"N Engl J Med"},{"key":"931_CR13","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung Cancer. N Engl J Med. 2018;378:2078\u201392.","journal-title":"N Engl J Med."},{"key":"931_CR14","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","volume":"379","author":"L Paz-Ares","year":"2018","unstructured":"Paz-Ares L, Luft A, Vicente D, et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. 2018;379:2040\u201351.","journal-title":"N Engl J Med"},{"key":"931_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/cncr.24703","volume":"116","author":"XS Wang","year":"2010","unstructured":"Wang XS, Shi Q, Lu C, Basch EM, Johnson VE, Mendoza TR, et al. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer. 2010;116:137\u201345.","journal-title":"Cancer"},{"key":"931_CR16","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1200\/JCO.2006.07.1126","volume":"24","author":"XS Wang","year":"2006","unstructured":"Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS. Longitudinal study of the relationship between chemoradiation therapy for non\u2013small-cell lung cancer and patient symptoms. J Clin Oncol. 2006;24:4485\u201391.","journal-title":"J Clin Oncol"},{"key":"931_CR17","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/S0959-8049(05)80262-X","volume":"29A","author":"PJ Hollen","year":"1993","unstructured":"Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: Testing the lung cancer symptom scale (LCSS). Eur J Cancer. 1993;29A:S51\u20138.","journal-title":"Eur J Cancer"},{"key":"931_CR18","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/B978-1-4377-1604-7.00197-4","volume-title":"Goldman\u2019s Cecil medicine","author":"DS Ettinger","year":"2012","unstructured":"Ettinger DS. Lung cancer and other pulmonary neoplasms. In: Goldman L, Schafer AI, editors. Goldman\u2019s Cecil medicine, vol. 2. 24th ed. New York: Elsevier; 2012. p. 1264\u201371.","edition":"24"},{"key":"931_CR19","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1200\/JCO.2006.05.8073","volume":"24","author":"A Bezjak","year":"2006","unstructured":"Bezjak A, Tu D, Seymour L, Clark G, Trajkovic A, Zukin M, et al. Symptom improvement in lung cancer patients treated with erlotinib: Quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol. 2006;24:3831\u20137.","journal-title":"J Clin Oncol"},{"key":"931_CR20","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1200\/JCO.2004.01.106","volume":"22","author":"L Butler","year":"2004","unstructured":"Butler L, Bacon M, Carey M, et al. Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial. J Clin Oncol. 2004;22:2461\u201368.","journal-title":"J Clin Oncol"},{"key":"931_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00520-013-1959-4","volume":"22","author":"S Iyer","year":"2014","unstructured":"Iyer S, Roughley A, Rider A, Taylor-Stokes G. The symptom burden of non-small cell lung cancer in the USA: A real-world cross-sectional study. Support Care Cancer. 2014;22:181\u20137.","journal-title":"Support Care Cancer"},{"key":"931_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3816\/CLC.2006.n.001","volume":"7","author":"JS Temel","year":"2006","unstructured":"Temel JS, Pirl WF, Lynch TJ. Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer. 2006;7:241\u20139.","journal-title":"Clin Lung Cancer"},{"key":"931_CR23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5603\/ARM.27957","volume":"75","author":"J Rolski","year":"2007","unstructured":"Rolski J, Zeme\u0142ka T, Jasi\u00f3wka M, Czyzewicz G, Kojs-Pasi\u0144ska E. Chemotherapy of advanced non small cell lung cancer: Effect on survival and symptoms affecting quality of life. Pneumonol Alergol Pol. 2007;75:343\u20138.","journal-title":"Pneumonol Alergol Pol"},{"key":"931_CR24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1200\/JCO.2009.25.4052","volume":"28","author":"AJ Davidoff","year":"2010","unstructured":"Davidoff AJ, Tang M, Seal B, Edelman MJ. Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin oncol. 2010;28:2191\u201397.","journal-title":"J Clin oncol"},{"key":"931_CR25","doi-asserted-by":"publisher","first-page":"S337","DOI":"10.1097\/01.JTO.0000283148.83670.80","volume":"2","author":"S Burdett","year":"2007","unstructured":"Burdett S, David J, Stewart L, Tierney J, Le Pechoux C. On behalf of the NSCLC Collaborative Group. Supportive Care and chemotherapy vs. supportive care alone in advanced non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data from randomized controlled trials. J Thor Oncol 2007;2:S337.","journal-title":"J Thor Oncol"},{"issue":"1","key":"931_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5603\/ARM.27531","volume":"81","author":"J Milanowski","year":"2013","unstructured":"Milanowski J, Szmygin-Milanowska K. Treatment of non-small cell lung cancer: Where we are? Pneumonol Alergol Pol. 2013;81(1):55\u201360.","journal-title":"Pneumonol Alergol Pol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00931-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-00931-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00931-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T18:43:44Z","timestamp":1721155424000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-00931-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-00931-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"4 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}